[1] MAURI L,KEREIAKES D J,YEH R W,et al.Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents[J].N Engl J Med,2014,371:2155-2166.
[2] PALMERINI T,BENEDETTO U,BACCHI-REGGIANI L,et al.Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation:a pairwise and Bayesian network meta-analysis of randomised trials[J].Lancet,2015,385:2371-2382.
[3] BELKACEMI A,AGOSTONI P,NATHOE H M,et al.First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial:a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic,intravascular,functional,and clinical outcomes[J].J Am Coll Cardiol,2012,59(25):2327-2337.
[4] BESIC K M,STROZZI M,MARGETIC E,et al.Drug-eluting balloons in patients with non-ST elevation acute coronary syndrome[J].J Cardiol,2015,65(3):203-207.
[5] LOH J P,WAKSMAN R.Paclitaxel drug-coated balloons:a review of current status and emerging applications in native coronary artery de novo lesions[J].JACC Cardiovasc Interv,2012,5:1001-12.
[6] JACKSON D,TONG D,LAYLAND J.A review of the coronary applications of the drug coated balloon[J].Int J Cardiol,2017,226:77-86.
[7] SHUSTER J J.Review:Cochrane handbook for systematic reviews for interventions,Version 5.1.0[J].Res Synth Methods,2011,2(2):126-130.
[8] GARACIATOUCHARD A,GOICOLEA J,SABATE M,et al.A randomized trial of paclitaxel-eluting balloon after bare metal stent implantation vs bare metal stent in ST elevation myocardial infarction (The PEBSI study)[J].Eurointervention,2015,65(10):1587-1594.
[9] VOS N S,DIRKSEN M T,VINK M A,et al.Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in primary percutaneous coronary intervention in Amsterdam (PAPPA):One-year clinical outcome of a pilot study[J].Eurointervention,2014,10(5):584-590.
[10] HO H H,TAN J,OOI Y W,et al.Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention[J].World J Cardiol,2015,7(6):311-4.
[11] MAHMOOD Z A S,ZEYMER U,WALISZEWSKI M,et al.The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions:an analysis of a prospective ‘real world’ registry[J].Springerplus,2016,5(1):373.
[12] CORTESE B.Nanoparticle sirolimus coated balloon for the treatment of ACS patients:results from the Nanolute Registry[M].Transcatheter cardiovascular treatment,www.tctmd.com,2016.
[13] BENEZET J,AGARRADO A,GUTIERREZ-BARRIOS A,et al.Comparison of two different drug-coated balloons for the treatment of in-stent restenosis:A long-term single-centre experience[J].Cardiovasc Revasc Med,2016,17(3):176-180. |